The drugmaker's approved treatment, Kisunla (donanemab), works by binding to deposited amyloid plaque in the brain. Its phase 3 Alzheimer's asset, remternetug, also binds to amyloid plaques. It is ...

Dr Dennis Gross's Alpha Beta Glow Pads: why you must try this genius facial tanner - If you buy one beauty item this week ...

World Thalassemia Day was observed on 8 May. India records between 10,000 and 15,000 new cases of Thalassemia Major every ...